Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.
Low expression of BAZ2B may promote breast cancer progression by reshaping tumour metabolism. Read on to learn more.
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Next-Generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback